Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in CDXS — Codexis, Inc.

CIK 1692234 Seattle, WA
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$696,291
+$600,971 QoQ
Shares Held
308,095
+426.8% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 148 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. CDXS ranks #137 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in CDXS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $696,291 308,095
2026-03-31 $95,320 58,479
2025-12-31 $96,252 59,051
2025-09-30 $118,200 48,443
2025-06-30 $92,806 38,036
2025-03-31 $126,252 46,935
2024-12-31 $249,469 52,300
2024-09-30 $182,770 59,342
2024-06-30 $240,843 77,692
2024-03-31 $270,854 77,609
2023-12-31 $327,849 107,492
2023-09-30 $284,379 150,467
2023-06-30 $308,912 110,326
2023-03-31 $452,919 109,401
2022-12-31 $518,424 111,250
2022-09-30 $596,176 98,379
2022-03-31 $2,798,812 135,733
2021-12-31 $3,094,853 98,972
2020-03-31 $209,918 18,810